Nalidixic Acid FDA Link

A synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA GYRASE.

Also Known As:

Nalidixate Sodium; Nalidixate Sodium Anhydrous; Nevigramon; Sodium Nalidixic Acid, Anhydrous; Sodium Nalidixic Acid, Monohydrate; Acid, Nalidixic; Anhydrous, Nalidixate Sodium; Sodium Anhydrous, Nalidixate; Sodium, Nalidixate; Nalidixin; 1,8-Naphthyridine-3-carboxylic acid, 1-ethyl-1,4-dihydro-7-methyl-4-oxo-

Pharmalogical Action Categories:

Anti-Bacterial Agents
Topoisomerase II Inhibitors

Heterocyclic Compounds: 198
- Fused-Ring Heterocyclic Compounds
  - 2-Ring Heterocyclic Compounds
    - Quinolines: 146
      - Quinolones: 2938
        4-Quinolones: 66
        Nalidixic Acid: 523
    - Naphthyridines: 2
      - Nalidixic Acid: 523

Muhammad Yasin Khan Selected Research

Muhammad Yasin Khan Research Topics

Disease

Drug/Important Bio-Agent (IBA)